ArticleBreast cancer (Dove Medical Press)2026
Drivers of Variation in the Rate of Radiotherapy Following Lumpectomy in the Military Health System.
Article in Breast cancer (Dove Medical Press), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Radiation therapy (RT) following lumpectomy has been shown to improve survival. However, little is known about drivers of RT within the Military Health System (MHS). We examined how factors previously shown to affect RT rates after lumpectomy in the civilian population and factors exclusive to service members such as rank, service branch, and MHS catchment area are associated with undergoing RT within 6 months after lumpectomy. Materials and methods: We conducted a retrospective cohort study using the 2007-2019 MHS Data Repository (MDR) to obtain data from 9681 service members or dependents who had lumpectomy to treat breast cancer and remained in the system at least 6 months after their lumpectomy. We used Cox-Proportional Hazards to model time until their first RT session and examined how demographic and service-related factors affected rates of RT following lumpectomy. Results: Within the sample, 57.4% of lumpectomy patients received RT within 6 months after surgery. Receiving timely RT was found to be positively associated with older age (Cox Model Benefit Ratio 95% CI [1.01, 1.02]), senior rank (Benefit Ratio 95% CI [1.00, 1.31]), and having a Mental Health diagnosis (Benefit Ratio 95% CI [1.40, 1.60]) when controlling for all other variables in the model. Using catchment area RT rates from 2007 to 2017 and modelling data from 2018 to 2019, it was found that timely RT is positively associated with being in the catchment areas at the top quartile of historical RT rates (Benefit Ratio 95% CI [1.06, 1.47]). Conclusion: We identify important variation in receiving RT after lumpectomy both when comparing MHS rates to known rates in the general population and when comparing rates across catchment areas where military personnel are stationed. Lumpectomy patients in the MHS who are stationed in catchment areas with higher historical RT rates are themselves more likely to undergo RT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.